It’s always interesting to see new companies pop up on the HCI 100 list, but it’s even more fun to speculate about which companies will make the list two or three years from now. Healthcare Informatics interviewed the CEOs of five promising companies to keep an eye on. Read More
Last week, Towers Watson bought Extend Health, which allows retirees to choose from thousands of private Medicare plans according to their needs, instead of having their employer make the decision. Towers paid $435 million. One of the winners in that transaction was venture capital firm Psilos, which made in five years 10 times its investment in Extend Health— an unusual occurrence in health IT. Read More
Maybe it is possible to make big returns on health care investments.
Psilos Group said Monday that it earned a 10x return on the sale of portfolio company Extend Health to Towers Watson. Towers Watson announce the $435 million acquisition on Sunday. Read More
Transaction brings together Towers Watson’s benefits expertise and experience with Extend Health’s largest private Medicare exchange, allowing employers to provide a cost-effective benefit and retirees to increase plan choice and buying power.
NEW YORK and SAN MATEO, May 13, 2012 — Towers Watson (NYSE, NASDAQ: TW), a global professional services company, announced today that it has signed an agreement to acquire Extend Health, Inc., which operates the largest private Medicare exchange in the United States. We believe that this combination of two market leaders will provide innovative, best-in-class health care solutions that combine specialized retiree medical transition consulting with the choice and cost advantages of individual Medicare plans purchased on a private exchange. The two organizations announced a strategic alliance last August. Read More
NEW YORK, NY and CORTE MADERA, CALIF. – April 17, 2012 –Consumers are becoming more engaged in their healthcare and want to be financially rewarded for their efforts says healthcare investment firm Psilos Group in their new report called 2012 PSILOS Outlook on Healthcare Economics & Innovation. PSILOS says that incentive programs and personalization are critical factors for enticing consumers to be more active in the day-to-day management of their health and wellness, and lowering the overall cost burden of healthcare today. Read More
PARIS, March 13, 2012 – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), the leader in the endomicroscopy market, announced that the American Medical Associaton’s (AMA) CPT (Current Procedural Terminology) Editorial Panel has approved three Category I codes to cover use of Cellvizio in the gastrointestnal tract.
Cellvizio, the world’s smallest microscope, is the frst system designed to provide live cellular-level images of internal human tissues during endoscopic procedures. Read More
It’s no secret successful healthcare only works with well-engaged patients. But, whether it’s a lack of usable technology or unproven theories, recent research has shown patients are still not interested in managing their care.
Steve Krupa, managing member at healthcare investment firm PSILOS, outlines four reasons why patients aren’t managing their healthcare. Read More
Until now, drawing blood has been an unavoidable component of being tested for prediabetes and diabetes. Nobody enjoys the process, and it probably makes many people shy away from undergoing diagnosis at all.
But all that could change with the advent of a new diagnostic device that involves no pricks, no blood draw, no fasting, and no waiting for lab results. It is already approved for use in Canada and Europe, and it is being evaluated as an investigational tool in the United States. Read More